ATE364697T1 - Edg8-rezeptor, dessen herstellung und verwendung - Google Patents

Edg8-rezeptor, dessen herstellung und verwendung

Info

Publication number
ATE364697T1
ATE364697T1 AT01949287T AT01949287T ATE364697T1 AT E364697 T1 ATE364697 T1 AT E364697T1 AT 01949287 T AT01949287 T AT 01949287T AT 01949287 T AT01949287 T AT 01949287T AT E364697 T1 ATE364697 T1 AT E364697T1
Authority
AT
Austria
Prior art keywords
production
receptor
polynucleotides
edg8
edg8 receptor
Prior art date
Application number
AT01949287T
Other languages
English (en)
Inventor
Evi Kostenis
Johann Gassenhuber
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP00108858A external-priority patent/EP1149907A1/de
Priority claimed from EP00116589A external-priority patent/EP1178110A1/de
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of ATE364697T1 publication Critical patent/ATE364697T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
AT01949287T 2000-04-26 2001-04-14 Edg8-rezeptor, dessen herstellung und verwendung ATE364697T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00108858A EP1149907A1 (de) 2000-04-26 2000-04-26 EDG8 Rezeptor, dessen Herstellung und Verwendung
EP00116589A EP1178110A1 (de) 2000-08-01 2000-08-01 EDG8 Rezeptor für Sphingosine 1-Phosphate , dessen Herstellung und Anwendung

Publications (1)

Publication Number Publication Date
ATE364697T1 true ATE364697T1 (de) 2007-07-15

Family

ID=26070860

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01949287T ATE364697T1 (de) 2000-04-26 2001-04-14 Edg8-rezeptor, dessen herstellung und verwendung

Country Status (14)

Country Link
US (2) US20020099191A1 (de)
EP (1) EP1278850B1 (de)
JP (1) JP5139617B2 (de)
KR (1) KR100790329B1 (de)
AT (1) ATE364697T1 (de)
AU (2) AU7048901A (de)
BR (1) BR0110248A (de)
CA (1) CA2406725C (de)
DE (1) DE60128906T2 (de)
IL (2) IL152378A0 (de)
MX (1) MXPA02010241A (de)
NO (1) NO331197B1 (de)
NZ (1) NZ522215A (de)
WO (1) WO2001081573A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812335B1 (en) 1999-03-23 2004-11-02 The Regents Of The University Of California Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same
US20040185534A1 (en) * 2000-10-02 2004-09-23 Knudsen Ida Molgaard Industrial-scale serum-free production of recombinant proteins in mammalian cells
EP1325127B1 (de) * 2000-10-02 2009-03-11 Novo Nordisk Health Care AG Verfahren zur herstellung vitamin-k-abhängiger proteine
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
JP2005522184A (ja) * 2001-07-20 2005-07-28 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規のｇタンパク質共役受容体ｇａｖｅ８
EP1597580A2 (de) * 2002-11-13 2005-11-23 Bayer HealthCare AG Diagnostika und therapeutika für krankheiten, die mit dem menschlichen endothelial differentiation sphingolipid g-protein-gekoppelten rezeptor 5 (edg5) assoziiert sind
WO2005009469A1 (ja) * 2003-07-28 2005-02-03 Sumitomo Pharmaceuticals Co., Ltd. 新規血糖調節薬及びそのスクリーニング方法
US20090191578A1 (en) * 2004-07-27 2009-07-30 Merck & Co., Inc Canis sphingosine 1-phosphate receptor isoform 5
US8791100B2 (en) 2010-02-02 2014-07-29 Novartis Ag Aryl benzylamine compounds
JP2016518812A (ja) 2013-03-14 2016-06-30 ガラパゴス・ナムローゼ・フェンノートシャップＧａｌａｐａｇｏｓ Ｎ．Ｖ． 線維症治療において有用な分子標的及び前記標的のインヒビター

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
AU9794598A (en) * 1997-10-10 1999-05-03 Lxr Biotechnology Inc. Methods for detecting compounds which modulate the activity of an lpa receptor
JP2002531057A (ja) * 1998-08-19 2002-09-24 ミレニアム・ファーマシューティカルズ・インコーポレイテッド Ｅｄｇ受容体ファミリーに関連したｇタンパク質結合受容体である１４２７４受容体
WO2001004139A2 (en) * 1999-07-13 2001-01-18 Smithkline Beecham Corporation Human axor29 receptor
GB9923890D0 (en) * 1999-10-08 1999-12-08 Pfizer Ltd Novel polypeptide

Also Published As

Publication number Publication date
NO331197B1 (no) 2011-10-31
DE60128906D1 (de) 2007-07-26
KR20020097234A (ko) 2002-12-31
MXPA02010241A (es) 2004-09-06
EP1278850B1 (de) 2007-06-13
NZ522215A (en) 2004-05-28
WO2001081573A1 (en) 2001-11-01
BR0110248A (pt) 2003-01-07
EP1278850A1 (de) 2003-01-29
NO20025152L (no) 2002-12-13
DE60128906T2 (de) 2008-02-07
IL152378A (en) 2010-12-30
AU2001270489B2 (en) 2007-03-15
JP2003530882A (ja) 2003-10-21
US7141383B2 (en) 2006-11-28
NO20025152D0 (no) 2002-10-25
KR100790329B1 (ko) 2008-01-02
JP5139617B2 (ja) 2013-02-06
AU7048901A (en) 2001-11-07
US20030219874A1 (en) 2003-11-27
CA2406725C (en) 2013-01-15
IL152378A0 (en) 2003-05-29
US20020099191A1 (en) 2002-07-25
CA2406725A1 (en) 2001-11-01

Similar Documents

Publication Publication Date Title
BG108495A (en) 5-ht receptor ligands and uses thereof
TW200631594A (en) Toll like receptor 3 antagonists, methods and uses
ITUD20030092A1 (it) Protesi per l'articolazione della spalla.
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
WO2005000820A3 (fr) Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
ATE293448T1 (de) Benzo(d)azepin-derivative als 5-ht6-rezeptor- antagonisten
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
MXPA03002971A (es) Receptores de hematopoyetina hpr1 y hpr2.
ATE363531T1 (de) Claudin polypeptide
BRPI0112375B8 (pt) aplidinas como derivados antitumorais
DE60128906D1 (de) Edg8-rezeptor, dessen herstellung und verwendung
DE60304695D1 (de) 7-ARYLSULFONAMID-2,3,4,5-TETRAHYDRO-1H-BENZOiDöAZEPINE MIT 5-HT6 REZEPTOR AFFINITÄT ZUR BEHANDLUNG VON ZENTRALNERVENSYSTEMERKRANKUNGEN
DE50111331D1 (de) Neue verwendung von proteinhydrolysaten
EA200601220A1 (ru) Анти-trkc антитела-агонисты и способы их применения
SE9801455D0 (sv) New receptor
WO2003018798A3 (en) G-protein coupled receptor and dna sequences thereof
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
WO2002002630A3 (en) Hcn polypeptides and polynucleotides and their use in therapy
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
TNSN06272A1 (en) Use of antagonists of the cb1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
WO2003074656A3 (en) Rank-ligand-induced sodium/proton antiporter polypeptides
ATE265418T1 (de) Neue substituierte 3-phenoxy- und 3- phenylalkyloxy-2-phenyl-propylamine
SG158098A1 (en) Toll like receptor 3 antagonists, methods and uses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties